In recent years, China has carried out in-depth clinical trial supervision reform and established a clinical trial management system that is in line with international standards. However, a minority from the United States and other western countries still take the news reports voluntarily disclosed by Chinese media on the self-inspection & verification of clinical trials in 2016 as the basis, ignoring the achievements of China's drug regulatory reform, questioning the quality of existing pharmaceutical clinical trials in China, which has a negative affect the internationalization development of China's pharmaceutical innovation. This paper conducted an in-depth study on the work of launching background of the self-inspection & verification of clinical trial data in 2015 and the relevant data in the 2017 summary report, revealed the actual situation of the work at that time, analyzed the policy background behind the problems, and put forward policy recommendations to continue to optimize the management of pharmaceutical clinical trials.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |